Further research is needed to clarify the regulatory mechanisms of LASS2 in the inhibition of liver cancer progression, the possible LASS2 interaction proteins were identified by co-immunoprecipitation (co-IP)-coupled Liquid Chromatography-Mass Spectrometry (LC/MS) in Hepa1-6 hepatoma cells. This evidence concerns the gene CERS2 and liver cancer.